Skip to search formSkip to main contentSkip to account menu

E 4021

Known as: E-4021, E4021 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (4)

Phosphodiesterase InhibitorsPiperidinesPlatelet Aggregation InhibitorsQuinazolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Use of a selective type V phosphodiesterase inhibitor, PAPiSOL (E4021), in the treatment of pulmonary hypertension in the canine.
Pulmonary hypertension (PH) is a progressive disease characterized by chronic elevation in pulmonary arterial pressure (PAP… 
2000
2000
E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilateor effect of inhaled nitric oxide in isolated perfused rat lungs
1999
1999
Pathway in Adrenomedullin-Induced Vasodilation in the Rat − Role of Nitric Oxide
We previously reported that adrenomedullin (AM), a potent vasodilator peptide discovered in pheochromocytoma cells, stimulates… 
1995
1995
Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta : characterization and the effects of E4021
1994
1994
CARDIOHEMODYNAMIC EFFECTS OF A NOVEL SELECTIVE AND POTENT PHOSPHODIESTERASE V INHIBITOR, E4021, IN THE PIG